Sinusitis
is a common disorder where the sinus linings get inflamed & disrupt the
respiratory path of the patient. It is generally affected by a viral infection
or dust allergies. Some signs & symptoms include a plugged nose, thick
nasal mucus, and pain in the face. In addition, other signs & symptoms may
include headaches, sore throat, fever, poor sense of smell, and cough.
According
to study, “World
Drugs for Sinusitis Market Research Report 2024(Covering North America, Europe,
China, South East Asia, Japan and India)” the key companies operating
in the world drugs for sinusitis market are Sanofi, AstraZeneca Plc., Abbott
Laboratories, Bayer AG, Johnson & Johnson, Sun Pharmaceutical Industries
Ltd., Novartis AG, Bionorica SE, Merck and Co. Inc., Bristol-Myers Squibb,
Beximco Pharmaceuticals Ltd., Dr. Reddy's Laboratories, Amgen, Huasun, Pfizer,
Eli Lilly and Company, CHIESI Farmaceutici Spa, Intersect ENT Inc., Zydus
Cadila, GlaxoSmithKline Plc. The key players are acquiring numerous small &
medium scale businesses in order to increase their resource bank &
production capacity. Many companies are investing heavily on research &
development (R&D) activities in order to gain a technical edge over their
rivals and stay ahead in the competition of the control of global sinusitis
drugs market.
Based
on type, sinusitis drugs market is segmented into chronic sinusitis, recurrent
sinusitis, acute sinusitis and sub-acute sinusitis. Acute sinusitis starts with
cold like symptoms for instance stuffy nose, a runny and facial pain. Based on
product type, market is segmented into antibiotics, decongestants,
corticosteroids and others. Based on age-group, market is segmented into
teenagers, children and adults. Based on application, market is segmented into
neurology, musculoskeletal & spine, orthopedics, skin & integumentary
and cardiology & vascular. In addition, based on end-user, market is
segmented into surgical centers, hospitals and pharmacy store.
The
sinusitis drugs market is driven by rise in prevalence of sinusitis, followed
by increase in mergers & acquisitions, growth in number of respiratory
tract infection, huge development in the medical device sector, various
technological advancements in healthcare sector & pharmaceuticals
companies, rise in number of bacterial, fungal infections & allergic
reactions, increase in investment by key players in R&D, rise in cases of
chronic rhinosinusitis (CRS) and growth in awareness among people about
sinusitis treatment. However, unknown etiology of sinusitis, high cost
associated with drugs of sinusitis, surgical intervention for sinusitis
management, and the launch of generics may impact the market. Moreover, rise in
technological advancements and growth in number of chronic sinusitis patients
are key opportunities for market.
Based
on geography, the USA country holds major share, followed by Europe in
sinusitis drugs market owing to increase in incidence of sinusitis and rise in
innovative products in the country. The China and India countries are expected
to witness higher growth rate due to growth in awareness among people and
increase in number of bacteria & viruses infections over the forecast
period. It is projected that future of the market will be bright on account of
increase in demand of antibiotics and growth in development in sinusitis
treatments in developed & developing economies during the forecast period.
The global market is anticipated to grow at a CAGR of approximately 3.6% over
the next five years, will reach US $2410 million in 2024, from US $1950 million
in 2019.
To
know more, click on the link below:-
Related
Reports:-
Contact
Us:-
Ken
Research
Ankur
Gupta, Head Marketing & Communications
+91-9015378249
No comments:
Post a Comment